rs3218005
A SNP in the CDKN2BAS gene on chromosome 9. Its most notable genotype is C;C: Slightly higher (1.55x) risk for breast cancer
- Gene
- CDKN2BAS
- Location
- Chr 922,000,248 (GRCh38)
- Highest magnitude
- 1.5Minor
- Tested on
- 23andMe, AncestryDNA, FamilyTreeDNA
- Minor allele frequency
- 16%
Genotypes
Plus strand, as in 23andMe and AncestryDNA files.
SNPedia records rs3218005 on the minus strand: (A;A), (A;G), (G;G). Magnitude rates how notable a genotype is from 0 to 10, not how risky it is.
Frequency
Share of each genotype in 4 HapMap populations.
- AverageT;T 65% C;T 31% C;C 3%
- European ancestry (Utah)T;T 83% C;T 15% C;C 2%
- Han Chinese (Beijing)T;T 62% C;T 38% C;C 0%
- Japanese (Tokyo)T;T 59% C;T 32% C;C 9%
- Yoruba (Nigeria)T;T 57% C;T 40% C;C 3%
Related
Conditions, medicines and genes
Notes
From SNPedia
Notes
rs3218005 shows an association with breast cancer in a British study involving ~2300 patients. The odds ratio for the (G;G) vs (A;A) homozygotes is 1.55 (CI: 1.02-2.37, p=0.013). A common variant of the p16(INK4a) genetic region is associated with physical function in older people. Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression.
Source and license
Adapted from rs3218005 on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.
SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.